WebThe Swedish biotech company Biolipox AB and Inflazyme Pharmaceuticals Ltd, a Canadian biopharmaceutical company located in Vancouver and listed on the Toronto Stock Exchange (TSX-IZP), have entered into a definitive asset purchase agreement whereby Biolipox will acquire the majority of Inflazyme’s assets for a total gross proceeds of CAD … WebAt a glance Originator Inflazyme Pharmaceuticals Class Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors Orphan Drug Status No Highest Development Phases No development reported Inflammation; …
Inflazyme Pharmaceuticals to acquire Adprotech
WebInflazyme Pharmaceuticals is actively using 6 technologies for its website, according to BuiltWith. These include Apache, PHP, and Google Adsense. UNLOCK PREMIUM DATA WITH DATABOOST Patents and Trademarks by IPqwery. Edit Patents and Trademarks by IPqwery Section. Overview . WebInflazyme Pharmaceuticals Ltd. is a bio-pharmaceutical company specializing in the design, discovery and commercialization of novel generations of drugs which combat such major diseases as asthma, ... Inflazyme's new compounds, Apanol, Tiesole and Bispan are known by the group name IZP-94005. services duct
INFLAZYME PHARMA: koers Aandeel beurs CA45663E1025
WebInflazyme Pharmaceuticals's top competitors include Array Biopharma,BioMarck Pharmaceuticals, andIdenix Pharmaceuticals. Array Biopharma Unclaimed Array BioPharma is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted … Start … WebInflazyme Pharmaceuticals is a biopharmaceutical company engaged in the discovery, development and commercialization of therapies for the treatment of respiratory and … WebInflazyme Pharmaceuticals (Research & Development assets) General Information. Description. Portfolio of biotechnological research and development programs and … pam harbour